{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:08:02Z","timestamp":1778832482582,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","award":["113-FTN0016"],"award-info":[{"award-number":["113-FTN0016"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 114-E0007"],"award-info":[{"award-number":["NTUH 114-E0007"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["FEMH-2025-C-045"],"award-info":[{"award-number":["FEMH-2025-C-045"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jiph.2025.103089","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T17:26:40Z","timestamp":1764869200000},"page":"103089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of sodium-glucose co-transporter 2 inhibitors on the incidence of non-tuberculous mycobacteria infection in diabetes populations"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0304-4258","authenticated-orcid":false,"given":"Ping-Huai","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5925-8477","authenticated-orcid":false,"given":"Chung-Han","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang-Ming","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0466-7796","authenticated-orcid":false,"given":"Chung-Shu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Cih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0311-5148","authenticated-orcid":false,"given":"Chin-Chung","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2025.103089_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2025.103089_bib2","unstructured":"Noncommunicable diseases: Mortality [\u3008https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/ncd-mortality\u3009], Accessed November 23, 2025."},{"key":"10.1016\/j.jiph.2025.103089_bib3","first-page":"129","article-title":"Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management","volume":"8","author":"Nitzan","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jiph.2025.103089_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000181","article-title":"Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients","volume":"4","author":"Martins","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jiph.2025.103089_bib5","unstructured":"WHO: Global Tuberculosis report 2024. Accessed November 23, 2025."},{"key":"10.1016\/j.jiph.2025.103089_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2471\/BLT.10.085738","article-title":"Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases","volume":"89","author":"Restrepo","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jiph.2025.103089_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000666","article-title":"Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study","volume":"2","author":"Dobler","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiph.2025.103089_bib8","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1093\/cid\/ciaa1381","article-title":"Mortality and prognostic factors of nontuberculous mycobacterial infection in korea: a population-based comparative study","volume":"72","author":"Lee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.103089_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04511-22","article-title":"Type 2 diabetes mellitus- and complication-related risk of nontuberculous mycobacterial disease in a South Korean cohort","volume":"11","author":"Jeon","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiph.2025.103089_bib10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.4269\/ajtmh.20-1441","article-title":"Associations between diabetes mellitus and nontuberculous mycobacterium-caused diseases in taiwan: a nationwide cohort study","volume":"105","author":"Wang","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiph.2025.103089_bib11","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1038\/s41598-023-34576-z","article-title":"The factors associated with mortality and progressive disease of nontuberculous mycobacterial lung disease: a systematic review and meta-analysis","volume":"13","author":"Hwang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2025.103089_bib12","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.3390\/ijms23073651","article-title":"An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors","volume":"23","author":"Salvatore","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiph.2025.103089_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13098-024-01325-9","article-title":"Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus","volume":"16","author":"Zhang","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jiph.2025.103089_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154754","article-title":"Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling","volume":"133","author":"Ding","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jiph.2025.103089_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcjd.2024.04.009","article-title":"Association of sodium-glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors with pneumonia, COVID-19, and other adverse respiratory events in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"48","author":"Wang","year":"2024","journal-title":"Can J Diabetes"},{"issue":"5","key":"10.1016\/j.jiph.2025.103089_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102686","article-title":"The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis","volume":"18","author":"Lee","year":"2025","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2025.103089_bib17","unstructured":"Methodology WCCfDS: ATC\/DDD Index 2025. Accessed November 23, 2025."},{"key":"10.1016\/j.jiph.2025.103089_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jdiacomp.2017.02.018","article-title":"Diabetes complications severity index (DCSI)-update and ICD-10 translation","volume":"31","author":"Glasheen","year":"2017","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jiph.2025.103089_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/imm.12394","article-title":"Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections","volume":"144","author":"Hodgson","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.jiph.2025.103089_bib20","first-page":"442","article-title":"Type 2 Diabetes and its Impact on the Immune System","volume":"16","author":"Berbudi","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jiph.2025.103089_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1008922","article-title":"Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials","volume":"9","author":"Scisciola","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jiph.2025.103089_bib22","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1172\/JCI57817","article-title":"Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria","volume":"122","author":"Tan","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jiph.2025.103089_bib23","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/j.1582-4934.2009.00803.x","article-title":"Methylglyoxal modulates immune responses: relevance to diabetes","volume":"14","author":"Price","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jiph.2025.103089_bib24","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3390\/jcm8122219","article-title":"Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens, especially mycobacterium tuberculosis","volume":"8","author":"Ferlita","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jiph.2025.103089_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2007-979789","article-title":"Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells","volume":"28","author":"Reinhold","year":"1996","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jiph.2025.103089_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12916-016-0606-6","article-title":"\"Why me, why now?\" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection","volume":"14","author":"Lake","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.jiph.2025.103089_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109080","article-title":"The impact of SGLT2 inhibitors on inflammation: a systematic review and meta-analysis of studies in rodents","volume":"111","author":"Theofilis","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jiph.2025.103089_bib28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0024-3205(00)00622-6","article-title":"Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes","volume":"67","author":"Pickup","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.jiph.2025.103089_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112563","article-title":"AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation","volume":"146","author":"Entezari","year":"2022","journal-title":"Biomed Pharm"},{"key":"10.1016\/j.jiph.2025.103089_bib30","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.3390\/ijms19113495","article-title":"AMP-activated protein kinase and host defense against infection","volume":"19","author":"Silwal","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiph.2025.103089_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107492","article-title":"The SGLT2 inhibitor empagliflozin negatively regulates IL-17\/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK\/mTOR\/autophagy pathway","volume":"94","author":"Meng","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jiph.2025.103089_bib32","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/21505594.2017.1321191","article-title":"cGAS-STING-TBK1-IRF3\/7 induced interferon-\u03b2 contributes to the clearing of non tuberculous mycobacterial infection in mice","volume":"8","author":"Ruangkiattikul","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.jiph.2025.103089_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1074\/jbc.M116.763268","article-title":"AMP-activated Kinase (AMPK) promotes innate immunity and antiviral defense through modulation of stimulator of interferon genes (STING) signaling","volume":"292","author":"Prantner","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jiph.2025.103089_bib34","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jfma.2020.05.001","article-title":"Host immune response against environmental nontuberculous mycobacteria and the risk populations of nontuberculous mycobacterial lung disease","volume":"119","author":"Shu","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jiph.2025.103089_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4046\/trd.2018.0026","article-title":"Infection source and epidemiology of nontuberculous mycobacterial lung disease","volume":"82","author":"Jeon","year":"2019","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.jiph.2025.103089_bib36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.chest.2023.06.014","article-title":"Risk factors for nontuberculous mycobacterial pulmonary disease","volume":"164","author":"Loebinger","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jiph.2025.103089_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01675-22","article-title":"Stratification of nontuberculous mycobacterial disease risk in type 2 diabetes based on metformin use: a population-based cohort study in South Korea","volume":"67","author":"Kim","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2025.103089_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1463224","article-title":"Metformin improves mycobacterium avium infection by strengthening macrophage antimicrobial functions","volume":"15","author":"Mediaas","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiph.2025.103089_bib39","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.3390\/ijms24054785","article-title":"Metformin, empagliflozin, and their combination modulate ex-vivo macrophage inflammatory gene expression","volume":"24","author":"Arefin","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiph.2025.103089_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan's national health insurance research database: past and future","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jiph.2025.103089_bib41","doi-asserted-by":"crossref","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiph.2025.103089_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0453","article-title":"Sodium-glucose transport protein 2 inhibitor use for type 2 diabetes and the incidence of acute kidney injury in Taiwan","volume":"6","author":"Chung","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:16:20Z","timestamp":1778829380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125004381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1876034125004381"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103089","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of sodium-glucose co-transporter 2 inhibitors on the incidence of non-tuberculous mycobacteria infection in diabetes populations","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103089"}}